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Abstract 
Introduction: Human coronaviruses (HCoVs) circulate endemically in 
human populations, often with seasonal variation. We describe the 
long-term patterns of paediatric disease associated with three of 
these viruses, HCoV-NL63, OC43 and 229E, in coastal Kenya. 
Methods: Continuous surveillance of pneumonia admissions was 
conducted at the Kilifi county hospital (KCH) located in the northern 
coastal region of Kenya. Children aged <5 years admitted to KCH with 
clinically defined syndromic severe or very severe pneumonia were 
recruited. Respiratory samples were taken and tested for 15 virus 
targets, using real-time polymerase chain reaction. Unadjusted odds 
ratios were used to estimate the association between demographic 
and clinical characteristics and HCoV positivity. 
Results: From 2007 to 2019, we observed 11,445 pneumonia 
admissions, of which 314 (3.9%) tested positive for at least one of the 
HCoV types surveyed in the study. There were 129 (41.1%) OC43, 99 
(31.5%) 229E, 74 (23.6%) NL63 positive cases and 12 (3.8%) cases of 
HCoV to HCoV coinfection.  Among HCoV positive cases, 47% (n=147) 
were coinfected with other respiratory virus pathogens. The majority 
of HCoV cases were among children aged <1 year (66%, n=208), 
though there was was no change in the proportion infected by age. 
HCoV-OC43 was predominant of the three HCoV types throughout the 
surveillance period. Evidence for seasonality was not identified. 
Conclusions: Overall, 4% of paediatric pneumonia admissions were 
associated with three endemic HCoVs, with a high proportion of cases 
co-occurring with another respiratory virus, no clear seasonal pattern, 
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and with the age-distribution of cases following that of pneumonia 
admissions (i.e. highest in infants). These observations suggest, at 
most, a small severe disease contribution of endemic HCoVs in this 
tropical setting and offer insight into their potential future burden and 
epidemiological characteristics.
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            Amendments from Version 1
Revisions have been made to the manuscript based on 
recommendations from the reviewers. The following are the 
major changes:
 1.   In the methods section, we have highlighted the various 
sample collection methods that were used over time 
throughout the study period and further gave a brief 
discussion regarding the implication these changes could 
have on virus detection.
2.    In the results section, we have added a column of odds 
ratios for any of the three HCoV types that we tested
3.    In the discussion section, we have added text regarding 
the following:
We look at possible explanations on the observed variations 
of HCoV prevalence across age bands by exploring the linkage 
between potential community incidence and the likelihood for 
hospitalisation. 
We highlight in the limitations that HKU1 results were not 
included in this study because they were available for a short 
period (24 months) when PERCH was conducted compared to 
the entire period of our study (13 years).
We further discuss the potential under-estimation of HCoV 
prevalence based on our eligibility criteria which did not include 
other clinical features such as fever.
Any further responses from the reviewers can be found at 
the end of the article
REVISED
Introduction
To date, seven human coronaviruses (HCoVs) have been identi-
fied, of which four (NL63, HKU1, OC43 and 229E) are known 
to be endemic among humans1–4. Endemic HCoV types are 
detected in a small but non-negligible proportion of respira-
tory tract infections; mild cases occur across a wide age-range 
and severe disease is predominant in young children and the 
elderly5–8. A further three HCoVs have emerged in recent years 
and caused epidemics: SARS-CoV the agent of severe acute 
respiratory syndrome in China9, MERS-CoV the cause of Mid-
dle East respiratory syndrome in the Middle-East10 and most 
recently SARS-CoV-2, the aetiological agent of the current pan-
demic of coronavirus disease 2019 (COVID-19)11. To date, there 
are limited preventive options against HCoV infections and 
no effective anti-viral treatment12. Understanding the epi-
demiology of HCoVs can play a critical role in prediction, 
prevention and control of HCoV infection. In addition, data on 
endemic HCoVs may inform expectations for SARS-CoV-2 if 
it becomes endemic. Our study aims to describe the circula-
tion patterns of three endemic HCoVs (OC43, 229E, and NL63) 
over time using data from a long-term surveillance programme 
in a rural coastal setting in Kenya, 3° south of the equator.
Methods
Study setting
A prospective study was established in 2007 for long-term 
continuous respiratory virus surveillance among pneumonia 
admissions to Kilifi County Hospital (KCH)6 in order to develop 
improved epidemiological understanding, estimate disease 
burden and provide suitable baseline data for future vaccine 
studies. KCH is the referral hospital within the Kilifi Health and 
Demographic Surveillance System (KHDSS), in the north-
ern coastal region of Kenya13. The location experiences two 
rainy seasons approximately from April to July and October to 
December, with median maximum temperature of 33°C (IQR: 
31–36), median minimum temperature of 23°C (IQR: 22–24), 
and median relative humidity of 78% (IQR: 71–87) (unpublished 
weather station data). Children aged 1 day to 59 months admit-
ted to KCH with clinical symptoms of severe or very severe 
pneumonia were recruited. Written informed consent was sought 
from parents/guardians of the children prior to sample collec-
tion. In this paper we define severe pneumonia as history of 
cough or difficulty breathing and chest indrawing while very 
severe pneumonia is defined as history of cough or difficult 
breathing and at least one of inability to feed, prostration, uncon-
sciousness, or oxygen saturation of <90% by fingertip pulse 
oximetry. We use the term pneumonia to refer to all cases of clini-
cally severe or very severe pneumonia14. The variables extracted 
from the hospital surveillance database include; Demographic 
characteristics (sex, KHDSS residency status, age), presence/
absence of clinical features (history of cough, difficulty breath-
ing, cyanosis, nasal flaring, chest indrawing, crackles, wheeze, 
inability to drink, vomits everything, fever defined as axillary 
temperature ≥37.5° C, oxygen saturation levels, conscious level: 
agitated, lethargic, prostration or unconscious, pneumonia status: 
severe or very severe), laboratory test results, and hospi-
talisation outcomes (admission to the high dependency unit, 
discharge outcomes: alive or dead)
Laboratory methods
Specimens collected between January 2007 and December 2019 
were processed and screened for three HCoVs (OC43, NL63 
and 229E) and at least 12 other respiratory viral pathogens (RSV 
(A and B), rhinovirus, HCoVs (NL63, OC43, 229E), influenza 
(A, B and C), parainfluenza virus (1–4), adenovirus, and human 
metapneumovirus) using real-time polymerase chain reaction 
(RT-PCR). Sample testing was initially performed in 2007 
using the LightCycler Fast Start DNA MasterPLUS HybProbe 
kit (Roche)6, then multiplex RT-PCR using Qiagen Quantifast 
multiplex RT-PCR kit (Qiagen, United Kingdom) in triplex sets 
on an ABI 7500 system, from January 2007 until the present 
day15,16; additionally, a proportion of samples were tested using 
a 33-pathogen multiplex quantitative PCR (FTD Resp-33, Fast 
Track Diagnostics, Sliema, Malta) as part of the multi-country 
PERCH study17, between August 2011 and December 2013. 
A variety of collection methods was used: nasal wash (2007 to 
2009),  nasopharyngeal flocked swab (2010 to 2014), or com-
bined nasopharyngeal swab and oropharyngeal swab (2015 
onwards).
Data analysis
Data analysis was done using STATA version 13.0 (Stata Corp, 
College Station Texas, USA). Summary statistics (counts, pro-
portions, measures of central tendency and variation) are 
presented for continuous and categorical data as appropriate. 
We estimated unadjusted odds ratios to measure the association 
between demographic and clinical characteristics of the study 
participants and testing positive for HCoV. Three Poisson 
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regression models, one for each HCoV type, were used to 
investigate the presence of seasonality. In the models a trend 
variable was included and residuals plotted against month. Iden-
tification of a strong pattern by visual inspection of the residual 
plots would suggest presence of seasonality. The chi-square test 
of proportional trends was used to test for a linear trend in the 
proportions of samples tested or not tested for HCoV over 
time. To check for an association between categorical variables 
the chi-square test of association or Fisher’s exact test was 
used as appropriate. The analysis code is provided as Extended 
data18.
Ethical approval
This study was approved by the Kenya Medical Research 
Institute Scientific Ethics Review Unit (Approval number: 
KEMRI/SERU/CGMR-C/027/3178).
Results
Characteristics of patients infected with HCoVs
During the 13 years of surveillance, there were 49,409 pae-
diatric admissions of children aged 0–59 months at KCH. 
A total of 11,445 (23.2%) admissions were due to severe 
(n= 7808, 68%) and very severe (n=3637, 32%) pneumonia. 
Out of the eligible cases, 69.5% (n=7957) were tested for the 
three HCoVs while the remainder were not tested due to refusal 
of consent (13.8%), discharge (13%) or death (3.7%) prior to 
sample collection. Cases untested did not differ from those 
tested in age distribution or sex ratio, but were more likely to 
be very severe (40.0% versus 28.3%, Fishers exact P-value 
<0.001).
Of the 7957 children tested, 5312 (66.7%) were aged <1 year, 
1454 (18.3%) were aged 12–23 months, 620 (7.8%) were aged 
24–35 months and 571 (7.2%) were in the 36–59 months age 
band. The proportion of tested individuals with fever (axil-
lary temperature ≥37.5°C), cough and difficulty breathing was 
58.3%, 83.2%, 92.6%, respectively. A total of 314 (3.9%) tested 
positive for at least one of the three HCoV targets. Among 
the HCoV positives, 129 (41.1%) had OC43, 99 (31.5%) 
had 229E, 74 (23.6%) had NL63 and 12 (3.8%) had coinfec-
tions between the three HCoV types. Among all the samples 
tested, the overall prevalence of NL63 was 1% (n=80), 1.7% for 
OC43 (n=137) and 1.4% for 229E (n=109).
The characteristics of the patients positive for any and for 
each HCoV type or infection combination are described in 
Table 1. HCoV positive cases were predominantly children 
aged <1 year (66.2%) and those aged 12–23 months (18.2%). 
The burden of infection with at least one HCoV, among all 
pneumonia admissions, was highest in infants and decreased 
with increasing age (2.6% for those under 1 year and 0.7% 
for 12–23 months). The same pattern was seen for each indi-
vidual HCoV type (not shown). However, the proportion of 
samples testing positive for HCoV (3.9%) did not vary with age 
group (Fisher’s exact p-value = 0.753). Among all HCoV 
positive participants, mean age was 11 months (median 7 
months), there were fewer females than males and fewer with 
very severe compared to severe pneumonia. At least half of 
the HCoV positives presented with fever (58%) and nasal flaring 
(53%).
Clinical outcomes of HCoV-infected patients
Over a quarter of those positive for at least one of the three 
endemic HCoVs investigated in this study were admitted to the 
high dependency unit and of those positive for OC43, 13.5% 
(n=10) died while 7.8% (n=10) and 7.1% (n=7) died of those 
positive for NL63 and 229E, respectively. A large proportion 
of these deaths were observed among those with underlying 
co-morbidities (Figure 1). None of the HCoVs were statistically 
significantly associated with any of the specific clinical signs 
or outcomes investigated (p-values>0.05) except death among 
NL63 cases (Table 2); however, we had limited power to detect 
associations given the small number of HCoV positive cases.
Co-infection with other respiratory viruses
About 47% (n=147) of the 314 HCoV cases were co-infected 
with other viral respiratory pathogens; respiratory syncytial 
virus (RSV) and human rhinovirus (HRV) jointly accounted 
for >50% of all HCoV coinfections with other pathogens. A 
similar coinfection pattern was observed for each HCoV tested 
(Figure 2). Throughout the surveillance period, there were 
three cases (one of NL63 and two of OC43) aged <1 year that 
were readmitted and tested positive for the same HCoV as the 
first admission. The NL63 readmission occurred 10 days after 
discharge from the first admission while the OC43 readmissions 
were at 3 and 21 days after discharge from the first admission. 
The NL63 case had a discharge diagnosis of neonatal sepsis 
for the first admission and gastroenteritis plus lower respira-
tory tract infection (LRTI) for the readmission. One of the 
OC43 cases had a discharge diagnosis of LRTI for both admis-
sions while the other had immunosuppression plus malnutrition 
in the first and immunosuppression plus septicaemia for the 
second admission.
Temporal patterns of different HCoVs
NL63 and OC43 were observed fairly consistently through-
out the surveillance period while fewer cases of HCoV-229E 
were observed from the middle of 2011 and were not detected 
subsequent to 2016 (Figure 3). The highest numbers of cases 
were observed in the periods April to June for NL63, June to 
September for OC43 and January to March for 229E. Pooling 
data for all HCoVs, there were more cases in the colder months 
(May to September) than the hotter months (October to April) 
(Figure 4), as for OC43, but NL63 was more common in the 
first half of the year, and 229E in the second half of the year. 
However, time series models did not indicate a seasonal pattern 
for any of the HCoVs (Figure 5) over the years. The proportion 
of samples tested for HCoV did not change over time among 
those with severe pneumonia ( 2(1) 3.11;χ =  p-value = 0.078) but 
changed among those with very severe pneumonia 2(1) 149.11;χ =   p-value < 0.001).
De-identified raw data for this study are available as Underlying 
data18.
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Discussion
We have described the circulation patterns of three endemic 
HCoVs (NL63, OC43 and 229E) in a long-term surveillance 
study of childhood pneumonia hospitalisations in coastal Kenya. 
We observed a small proportion of pneumonia admissions 
positive for one or more HCoVs (3.9%). While 65% of HCoV 
infections occurred in children in their first year of life (either 
cumulatively for all HCoVs or for each individual HCoV type), 
this reflected the age-distribution of pneumonia admissions to 
the ward. Hence, contrary to other reports19, HCoV did not differ 
by age and this might reflect no variation in age-specific com-
munity incidence of infection in children under five, together 
Table 1. Demographic and clinical characteristics of study children (aged under 5 years) admitted 
with severe or very severe pneumonia to Kilifi County Hospital, Kilifi, Kenya 2007–2019, by HCoV type 
(n=314).
Variable NL63 
(n=74)
OC43 
(n=129)
229E 
(n=99)
HCoVs 
coinfections 
(n=12)
Total 
(n=314)
n (%) n (%) n (%) n (%) n (%)
Age (months) Median (IQR) 8 (3-20) 7 (2-15) 8 (2-19) 5.5 (2-8.5) 7 (2-16)
Age categories 0–11 months 49 (66.2) 87 (67.4) 61 (61.6) 12 (91.7) 208 (66.2)
12–23 months 11 (14.9) 24 (18.6) 22 (22.2) 0 (0.00) 57 (18.2)
24–35 months 11 (14.9) 8 (6.2) 9 (9.1) 1 (8.3) 29 (9.2)
36–59 months 3 (4.0) 10 (7.8) 7 (7.1) 0 (0.00) 20 (6.4)
Sex Female 22 (29.7) 60 (46.5) 36 (36.4) 6 (50.0) 124 (39.5)
Male 52 (70.2) 69 (53.5) 63 (63.6) 6 (50.0) 190 (60.5)
Pneumonia status Severe 49 (66.2) 101 (78.3) 76 (76.8) 10 (83.3) 236 (75.2)
Very severe 25 (33.8) 28 (21.7) 23 (23.2) 2 (16.7) 78 (24.8)
Clinical 
presentation
Cough 55 (74.3) 112 (86.8) 85 (85.9) 12 (100.00) 264 (84.1)
Difficulty breathing 67 (90.5) 118 (91.5) 94 (95.0) 10 (83.3) 289 (92.1)
Fever* 43 (58.1) 75 (58.1) 54 (54.6) 10 (83.3) 182 (58.0)
Prostration or 
unconscious
17 (23.0) 18 (14.0) 14 (14.1) 1 (8.3) 50 (15.9)
Chest Indrawing 65 (87.8) 122 (94.6) 89 (89.9) 12 (100.00) 288 (91.7)
Wheeze 7 (9.5) 16 (12.5) 18 (18.2) 0 (0.0) 41 (13.1)
Crackle 27 (36.5) 44 (34.1) 40 (40.4) 3 (25.0) 114 (36.3)
Nasal flaring 40 (54.1) 66 (51.2) 54 (54.6) 6 (50.0) 166 (52.9)
Shock* 12 (16.2) 10 (7.8) 6 (6.1) 0 (0.00) 28 (8.9)
Hypoxemia (O2 
<90%)
12 (16.2) 14 (10.9) 13 (13.1) 1 (8.3) 40 (12.7)
Cyanosis 1 (1.4) 1 (0.8) 1 (1.0) 0 (0.00) 3 (1.0)
Inability to drink/
feed
5 (6.8) 11 (8.5) 7 (7.1) 0 (0.00) 23 (7.3)
Vomits everything 7 (9.5) 6 (4.7) 0 (0.00) 0 (0.00) 13 (4.14)
Duration of 
hospital stay
Mean (SD) 6.3 (6.8) 5.7 (6.1) 5.2 (5.5) 3.8 (2.3) 5.6 (6.0)
Median (IQR) 4 (3-6) 3 (2-7) 3 (2-6) 6.5 (3-10) 4 (2-6)
Outcomes HDU* 27 (36.5) 31 (24.0) 22 (22.2) 2 (16.7) 82 (26.1)
Died 10 (13.5) 10 (7.8) 7 (7.1) 0 (0.00) 27 (8.6)
* Fever is defined as axillary temperature ≥37.5°C, shock is defined as capillary refill of >3 seconds, temperature gradient or weak 
pulse volume. HDU indicates study participants who were critically ill and were transferred from the general ward to the high 
dependency unit.
** The high proportions of cough, difficulty breathing, chest indrawing, hypoxemia, prostratration or unconscious and inability to 
drink/feed among HCoV positive cases should be interpreted with caution because these clinical signs form part of our study’s 
eligibility criteria.
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Figure  1. Frequency distribution of discharge diagnosis for mortality cases admitted to Kilifi County Hospital, Kilifi, Kenya 
2007–2019, by HCoV type. LRTI=lower respiratory tract infection, CHD=congenital heart disease, TB=Tuberculosis, GE=Gastroenteritis.
with lack of variation in disease severity (likelihood of hospi-
talisation) across ages, or (ii) variation in age-specific commu-
nity incidence by age but with a disproportionate probability 
of hospitalisation. Our reported prevalence is equivalent to that 
from a long-term hospital surveillance of seasonal coronaviruses 
in Scotland (4%)8 but lower compared to a multi-centre 
study across Kenya for the same three HCoVs (26/417 6.2% 
versus 314/7643 3.9%; 2(1) 4.43,χ =  p-value=0.035)7. This latter 
study included locations with a wide range of climate con-
ditions that might influence prevalence; however, the study 
was not big enough to stratify by location.
We did not observe seasonal variation of HCoVs compared 
to some other respiratory viral pathogens like RSV, as previ-
ously reported from our site14. In addition, neither peak months 
for pneumonia admissions nor the long rainy periods (April 
to July) in Kilifi were associated with HCoV peaks. This is in 
contrast to data from temperate settings where seasonality 
of HCoVs has been reported8,20–22, with increased occurrence 
during the colder winter months. The HCoVs we have studied 
are known to continuously circulate among humans1, although 
in Kilifi we observed low numbers for all types. Of interest 
is that pneumonia associated with 229E admissions was not 
detected in the later years of the surveillance. We attempted 
to investigate if this was due to primers or probe mismatches. 
For all the three tested endemic CoVs we did not observe 
significant mismatches on the primer/probe pairs against data 
available from GenBank database although this investiga-
tion suffered a limitation of few sequences available globally 
in recent years (2015–2019) and none from East Africa. With 
the highest numbers and consistent presence compared to NL63 
and 229E, our results suggest that OC43 is the predominant 
HCoV type in the coastal region of Kenya.
The present study did not have a control group by which to 
assess an aetiological association between the HCoVs and 
pneumonia. In the PERCH multi-country case-control study17 
HCoVs contributed less than 1% of the etiological fraction. 
In our study the contribution to disease is not known (except 
for the relatively small set of samples from 2011–13 that were 
part of the PERCH study), but it is of note that around 50% 
co-occurred with another respiratory virus (most commonly with 
Page 6 of 26
Wellcome Open Research 2020, 5:150 Last updated: 21 OCT 2020
Table 2. Unadjusted Odds Ratios (ORs) for demographic and clinical characteristics and the hospitalisation outcomes for 
children (under 5 years) admitted with severe or very severe pneumonia to Kilifi County Hospital, Kilifi, Kenya 2007-2019 by 
the 3 HCoV types.
NL63 OC43 229E Any HCoV
OR (95% CI) p-
value
OR (95% CI) p-
value
OR (95% CI) p-
value
OR (95% CI) p-
value
Age 0–11 
months
Ref Ref Ref Ref
12–23 
months
0.74 (0.39-1.42) 0.369 0.92 (0.59-1.45) 0.723 1.15 (0.71-1.86) 0.569 1.00 (0.74 – 1.35) 0.994
24–35 
months
1.92 (1.02-3.61) 0.043 0.72 (0.35-1.48) 0.371 1.23 (0.63-2.39) 0.547 1.20 (0.81 – 1.79) 0.360
36–59 
months
0.51 (0.16-1.65) 0.263 0.98 (0.51-1.89) 0.949 0.93 (0.43-2.03) 0.854 0.89 (0.56 – 1.42) 0.627
Sex Female Ref Ref Ref Ref
Male 1.62 (1.01-2.60) 0.046 0.81 (0.58-1.14) 0.221 1.27 (0.86-1.88) 0.233 1,13 (0.89 – 1.42) 0.302
Cough No Ref Ref Ref Ref
Yes 0.64 (0.38-1.08) 0.098 1.43 (0.86-2.39) 0.168 1.37 (0.78-2.42) 0.268 1.07 (0.79 – 1.46) 0.671
Breathing 
difficulty
No Ref Ref Ref Ref
Yes 0.63 (0.31-1.27) 0.196 0.83 (0.46-1.52) 0.544 1.38 (0.61-3.17) 0.440 0.93 (0.61 – 1.41) 0.720
Fever* No Ref Ref Ref Ref
Yes 1.13 (0.72-1.78) 0.587 1.04 (0.73-1.46) 0.839 0.94 (0.65-1.38) 0.766 0.99 (0.79 – 1.24) 0.908
Prostration/ 
unconsciousness
No Ref Ref Ref Ref
Yes 1.44 (0.83-2.46) 0.189 0.85 (0.52-1.39) 0.517 0.84 (0.49-1.46) 0.543 1.00 (0.74 – 1.37) 0.982
Chest indrawing No Ref Ref Ref Ref
Yes 0.68 (0.33-1.37) 0.279 1.62 (0.75-3.48) 0.217 0.86 (0.44-1.65) 0.64 0.96 (0.64 – 1.44) 0.835
Inability to feed No Ref Ref Ref Ref
Yes 0.54 (0.22-1.35) 0.189 0.71 (0.38-1.32) 0.283 0.62 (0.29-1.34) 0.226 0.66 (0.43 – 1.02) 0.061
Hypoxemia 
(O2<90%)
No Ref Ref Ref Ref
Yes 0.92 (0.51-1.67) 0.780 0.58 (0.34-0.99) 0.046 0.64 (0.34-1.14) 0.131 0.68 (0.49 – 0.96) 0.026
Pneumonia 
status
Severe Ref Ref Ref Ref
Very 
severe
1.22 (0.76-1.95) 0.406 0.71 (0.47-1.06) 0.094 0.71 (0.45-1.12) 0.143 0.83 (0.64 – 1.08) 0.162
Hospital stay <= 4 
days
Ref Ref Ref Ref
> 4 
days
1.06 (0.68-1.65) 0.807 0.85 (0.60-1.21) 0.373 0.72 (0.49-1.08) 0.110 0.88 (0.70 – 1.11) 0.285
Death No Ref Ref Ref Ref
Yes 1.98 (1.02-3.87) 0.045 1.07 (0.56-2.05) 0.842 0.93 (0.43-2.03) 0.872 1.29 (0.86 – 1.93) 0.218
*Fever is defined as axilliary temperature ≥ 37.5° C
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Figure 2. Percentage distribution of coinfections between HCoVs and other viral pathogens for pneumonia cases admitted 
to Kilifi County Hospital, Kilifi, Kenya 2007–2019. RSV=respiratory syncytial virus (A and B), HRV=human rhinovirus, PIV=parainfluenza, 
FLU=influenza (A, B and C), hMPV= human metapneumovirus.
RSV), the risk was not age-dependent, there was no clear asso-
ciation between any of the viruses with the any of the specific 
clinical signs or outcomes investigated and in 26% of deaths 
with a HCoV detected there was a likely alternative diagnosis 
to pneumonia. This suggests the presence of incidental HCoV 
in Kilifi and other clinical groups (hence an under-estimation 
in this study), though causality of death outcomes was not 
differentially identified in this study. While we have been able to 
sequence the virus from a proportion of the positive specimens23,24, 
we cannot assume 100% specificity, and even a modest 
level of false positivity could account for many of the positive 
diagnoses and argues for caution in interpreting the prevalence 
estimates. Of relevance also is that few (~1%) of the 314 children 
positive for at least one HCoV were subsequently HCoV-positive 
readmissions. While this is a crude analysis which ignores 
censoring at the start and end of the surveillance, and alterna-
tive hospitals where patients may have been admitted, it might 
be an indicator of low probability of severe reinfection. 
Alternatively, these readmissions might be children with a 
prolonged infection having not fully recovered at their first 
discharge. In addition, HKU1 was only tested during the 
24 month period that PERCH study was conducted hence 
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Figure 3. Monthly prevalence (%) pneumonia admissions at Kilifi County Hospital, Kilifi, Kenya 2007–2019 by HCoV type. The 
panel shows proportions for all HCoVs (a), NL63 (b), OC43 (c) and 229E (d).
Figure 4. Proportion of monthly positive cases observed at Kilifi County Hospital, Kilifi, Kenya by HCoV type over a period of 
13 years (2007–2019). The primary y-axis denotes the proportion of samples positive for HCoV the average monthly maximum 
temperature in °C and relative humidity (%) while the secondary y-axis denotes the average monthly rainfall in millimetres.
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Figure 5. Plot of time series model residuals against month separated by HCoV type using pneumonia surveillance data at Kilifi 
County Hospital, Kilifi, Kenya 2007–2019. See Methods for statistical details.
samples tested for HKU1 were considered unrepresentative of 
the entire study period and therefore not included in this analysis.
Over the surveillance period, we have changed our sample 
collection and testing methods. This is a limitation; we did not 
conduct a sensitivity analysis to compare the different PCR 
methods, and the addition of an OP swab increases the number 
of viruses found by NP alone (by 14% for HCoVs)15. Some 
of the observed patterns may have been influenced by these 
changes. It should be noted that fever, either on history or 
as measured at the time of admission, was not an inclu-
sion criterion for eligibility, which might have influenced the 
prevalence of HCoV. If the endemic COVs are strongly associ-
ated with symptoms of fever, as is SARS CoV-2, then we might 
be under-estimating the prevalence due to a selection bias. 
However, interestingly, only 58% of the HCoV positive cases 
had axillary temperature of >=37.5°C. A further limitation is that 
only a fraction (70%) of pneumonia cases was tested for HCoV. 
We have previously shown that those untested tend to be more 
severely ill and less likely to be virus positive14. The propor-
tion tested has not substantially changed over time among 
individuals with severe pneumonia but changed among those 
with very severe pneumonia. Similarly, we did not observe a 
difference in the ages of those tested and those untested for 
HCoV across time. We employed various collection methods 
and these are known to differ in the range of viruses detected. 
For example, the addition of an OP swab to an NP  swab has 
been found to increase virus yield15.
In conclusion, in this tropical setting we find the three endemic 
coronaviruses were observe at low prevalence, not dissimi-
lar to influenza and metapneumovirus, but considerably lower 
that for RSV and human rhinovirus. There was no clear sea-
sonal variation. As the pandemic of COVID-19 takes its course, 
it is of interest to speculate whether the SARS-CoV-2 virus will 
become endemic and continuously co-circulate in the human 
population with the existing HCoVs7,25. The epidemiology 
of endemic HCoVs can be used to inform our expecta-
tions of SARS-CoV-2 in childhood, its potential severity and 
inter-species interactions and competition.
Data availability
Underlying data
Harvard Dataverse: Replication Data for: Surveillance of 
endemic human coronaviruses (HCoV-NL63, OC43 and 229E) 
associated with pneumonia in Kilifi, Kenya. https://doi.org/ 
10.7910/DVN/ZQ1DJY18.
This project contains the following underlying data: 
•     KCH_paed_ARI_surv_pneumo (CSV). (De-identified 
underlying data for each patient in the study.)
•     KCH_paed_ARI_surv_pneumo-1 (SAV). (De-identified 
underlying data for each patient in the study.)
•     GPOtieno_HCOV_Codebook (PDF). (Data dictionary and 
codebook.)
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Extended data
Harvard Dataverse: Replication Data for: Surveillance of 
endemic human coronaviruses (HCoV-NL63, OC43 and 229E) 
associated with pneumonia in Kilifi, Kenya. https://doi.org/ 
10.7910/DVN/ZQ1DJY18.
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•     1_descriptive_analysis (DO). (Scripts used to generate 
information in the tables, data on frequencies, HCOVs 
virus distributions and proportions.)
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•     3_ORs (DO). (Code to fit univariable logistic regression 
models for each HCoV type.)
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Data are available under the terms of the Creative Commons 
Attribution 4.0 International license (CC-BY 4.0).
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This study describes patterns of endemic human coronavirus detections over a thirteen year 
period among paediatric cases of pneumonia in coastal Kenya. 
 
The authors should be commended for the impressive collation of clinical features, discharge 
diagnosis, and hospitalisation outcomes alongside multiplex PCR tests which is rarely available for 
a study spanning this length of time. 
 
The manuscript is well written and clearly presented throughout. I do however have some 
concerns requiring clarification.
The authors mention in Methods that a variety of specimen types were collected. Could the 
authors clarify whether this is at the individual patient level? If relevant, I suggest authors 
describe how duplication of samples from individual patients was handled in the analyses 
1. 
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(since this can affect probabilty of virus detection and violates statistical assumptions of 
independent data points). 
 
Suggest authors add to Methods a brief outline of the changes in testing procedure over 
time (as mentioned in the Discussion) to aid interpretation of detection trends, as different 
specimens are likely associated with different probabilities of virus detection. 
 
2. 
It is unclear why the laboratory screen omitted HCoV-HKU1. Suggest the authors include a 
comment on the anticipated influence on the overall detection of HCoV. 
 
3. 
It is unclear whether exclusion of untested discharged patients (presumably milder cases) 
have led to an under-estimation of HCoV detection proportions. Suggest authors add a 
statement to describe any anticipated influence of this exclusion. 
 
4. 
The % of pneumonia cases with HCoV detected is clearly low. However, it would be helpful if 
the authors could discuss this result in the context of other common respiratory viruses 
detected among cases of pneumonia in this setting, such as influenza and RSV. 
 
5. 
Discussion page 6: “...suggests age is not a risk factor for coronavirus associated pneumonia 
hospital admission”. The role of age as a risk factor for pneumonia cannot be determined 
here without a non-pneumonia control group. Suggest authors reword this statement and 
consider whether the lack of variation in age-specific proportions may potentially reflect (i) 
no variation in age-specific community incidence of infection in children under five, together 
with lack of variation in severity (likelihood of hospitalisation) across ages, or (ii) variation in 
age-specific community incidence by age but with a disproportionate probability of 
hospitalisation. 
 
6. 
Discussion page 9: “...and in 26% of deaths with a HCoV detected there was a likely 
alternative diagnosis to pneumonia”. This seems to suggest the role of HCoV on overall 
hospital burden may be under-estimated by pneumonia cases. Although not an aim of the 
study, I suggest the authors consider adding a brief comment regarding the generalisability 
of their findings to other clinical groups to place the results into a wider context. 
 
7. 
Discussion page 9: Can the authors comment on the possibility that readmissions reflect 
prolonged virus shedding, rather than indicating reinfection? Longest duration between 
admissions of 21 days possibly bordering an anticipated peak detection within first few 
weeks (e.g. for SARS-CoV-21). Suggest authors consider adding a brief statement to include 
this possibility. 
 
8. 
Discussion page 10: “ fever... was not an inclusion criterion for eligibility, which might have 
influenced the prevalence of HCoV”. Suggest authors make clear the anticipated direction of 
effect on the prevalence - presumably underestimation? 
 
9. 
Discussion page 10: “...there was a significant age difference for those tested and those 
untested for HCoV across time.” This statement seems to be at odds with Results page 3 
“..cases untested did not differ from those tested in age distribution..” Suggest the authors 
reword as appropriate. 
 
10. 
 
Page 14 of 26
Wellcome Open Research 2020, 5:150 Last updated: 21 OCT 2020
Conclusions page 10: “...little evidence of a substantial aetiological contribution...”: The 
aetiological role of HCoV cannot be established without a control group (as the authors do 
mention on page 9) i.e. it is not known whether the prevalence of HCoV is lower among 
cases of ARI without pneumonia. Suggest authors rephrase to put the low HCoV detections 
within the context of relative contribution of pathogens/other causes to disease aetiology 
i.e. most pneumonia cases are attributable to other causes. 
 
11. 
Although presumably outside the scope of this study to analyse, I suggest the authors 
consider commenting briefly on any potential role of coinfecting respiratory bacteria on 
HCoV-associated pneumonia in this population; bacterial coinfection may influence the 
chance of pneumonia/testing for viruses.
12. 
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Grieven Otieno, Kenya Medical Research Institute-Wellcome Trust Research Programme, 
Kilifi, Kenya 
We wish to thank the reviewer for the detailed reviewer of the manuscript and the 
suggested changes/edits. Please see below our responses: 
 
The authors mention in Methods that a variety of specimen types were collected. 
Could the authors clarify whether this is at the individual patient level? If relevant, I 
suggest authors describe how duplication of samples from individual patients was 
handled in the analyses (since this can affect probabilty of virus detection and violates 
statistical assumptions of independent data points).
1. 
  
Response: We collected one sample type per person, but the type varied over time, and we 
have indicated this in the Methods text of the manuscript 
 
Suggest authors add to Methods a brief outline of the changes in testing procedure 
over time (as mentioned in the Discussion) to aid interpretation of detection trends, 
as different specimens are likely associated with different probabilities of virus 
detection.
1. 
  
Response: We have made the change to the methods section as suggested by the reviewer. 
  
 
It is unclear why the laboratory screen omitted HCoV-HKU1. Suggest the authors 
include a comment on the anticipated influence on the overall detection of HCoV.
1. 
  
Response: We added a comment to the limitations of the study.   
  
 
It is unclear whether exclusion of untested discharged patients (presumably milder 
cases) have led to an under-estimation of HCoV detection proportions. Suggest 
authors add a statement to describe any anticipated influence of this exclusion.
1. 
  
Response: We recognise that eligible but untested individuals represent a possible bias. We 
state that the untested tended to be the more severe, and these are an important group, 
whose omission might lead to an under-estimate of the the role of HCoVs in sever disease. 
Note however, that the prevalence of HCoV infection (any type) was less prevalent amongst 
those with hypoxemia (a feature of very severe pneumonia). 
  
 
The % of pneumonia cases with HCoV detected is clearly low. However, it would be 
helpful if
1. 
the authors could discuss this result in the context of other common respiratory viruses 
detected among cases of pneumonia in this setting, such as influenza and RSV. 
  
Response: We have previously presented in several papers that relative to RSV and 
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rhinovirus the prevalence of all other viruses (including influenza) is low and not dissimilar 
to that of the HCoVs - Berkley et al JAMA 2010 May 26;303(20):2051-7.  doi: 
10.1001/jama.2010.675 and Onyango et al  J Infect Dis . 2012 Dec 15;206 Suppl 1(Suppl 
1):S61-7. doi: 10.1093/infdis/jis536,  and  Otieno et al BMC Infect Dis  . 2019 Aug 30;19(1): 
757.doi: 10.1186/s12879-019-4381-9 
 
Discussion page 6: “...suggests age is not a risk factor for coronavirus associated 
pneumonia hospital admission”. The role of age as a risk factor for pneumonia cannot 
be determined here without a non-pneumonia control group. Suggest authors 
reword this statement and consider whether the lack of variation in age-specific 
proportions may potentially reflect (i) no variation in age-specific community 
incidence of infection in children under five, together with lack of variation in severity 
(likelihood of hospitalisation) across ages, or (ii) variation in age-specific community 
incidence by age but with a disproportionate probability of hospitalisation.
1. 
  
Response: We have made the change as suggested by the reviewer and expounded on possible 
role the age structure of the community plays on our findings.
Discussion page 9: “...and in 26% of deaths with a HCoV detected there was a likely 
alternative diagnosis to pneumonia”. This seems to suggest the role of HCoV on 
overall hospital burden may be under-estimated by pneumonia cases. Although not 
an aim of the study, I suggest the authors consider adding a brief comment 
regarding the generalisability of their findings to other clinical groups to place the 
results into a wider context.
1. 
  
Response: We have added a statement indicating the possible occurrence of HCoV in other 
clinical groups in Kilifi hence potential underestimation of the proportion of deaths.
Discussion page 9: Can the authors comment on the possibility that readmissions 
reflect
1. 
prolonged virus shedding, rather than indicating reinfection? Longest duration between 
admissions of 21 days possibly bordering an anticipated peak detection within first few 
weeks (e.g. for SARS-CoV-21). Suggest authors consider adding a brief statement to include 
this possibility. 
  
Response: It is possible these are prolonged infections rather than reinfections and we 
have added the following to the text in the discussion: "...probability of severe reinfection. 
Alternatively, these readmissions might be children with a prolonged infection having not 
fully recovered at their  first discharge" 
 
Discussion page 10: “ fever... was not an inclusion criterion for eligibility, which might 
have
1. 
influenced the prevalence of HCoV”. Suggest authors make clear the anticipated direction of 
effect on the prevalence - presumably underestimation? 
  
Response: This is possible, but we don't know that these endemic HCoVs behave like SRAS-
CoV-2 ie are strongly associated with fever, hence again difficult to speculate as to which 
direction. We therefore added this statement to the limitations “ If the endemic COVs are 
strongly associated with symptoms of fever, as is SARS=CoV-2, then we might be under-
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estimating the prevalence due to a selection bias”. 
  
Discussion page 10: “...there was a significant age difference for those tested and those 
untested for HCoV across time.” This statement seems to be at odds with Results page 3 
“..cases untested did not differ from those tested in age distribution..” Suggest the authors 
reword as appropriate. 
  
Response: We have made the change as suggested by the reviewer. 
  
Conclusions page 10: “...little evidence of a substantial aetiological contribution...”: The 
aetiological role of HCoV cannot be established without a control group (as the authors do 
mention on page 9) i.e. it is not known whether the prevalence of HCoV is lower among 
cases of ARI without pneumonia. Suggest authors rephrase to put the low HCoV detections 
within the context of relative contribution of pathogens/other causes to disease aetiology 
i.e. most pneumonia cases are attributable to other causes. 
  
Response: We have made the change as suggested by the reviewer. 
  
Although presumably outside the scope of this study to analyse, I suggest the authors 
consider commenting briefly on any potential role of coinfecting respiratory bacteria on 
HCoV-associated pneumonia in this population; bacterial coinfection may influence the  
chance of pneumonia/testing for viruses. 
  
Response: We had very low proportions of bacterial infections among the positive cases: 
NL63 (2/74=2.7%), OC43 (3/129=2.3%), 229E (2/99=2.02%). We feel there is too little co-
infection to allow speculation on this.  
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Thank you for the opportunity of reviewing this well-written manuscript by the accomplished 
research team at Kilifi. They describe the prevalence of endemic human coronavirus (HCoV) 
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pneumonia hospitalisations in children <5 years of age in Kilifi over a 13-year surveillance period. 
 
Major comments:
Why was HCoV-HKU1 not included in the surveillance of endemic human coronaviruses in 
this study? Lack of testing for HCoV-HKU1 should be mentioned as a limitation of the study.
PERCH samples were included in the analysis, which would have included HCoV-
HCoV-HKU1: mention should be made that, as HKU1 was only tested for in the 24-
month PERCH surveillance period, it was considered to be under-represented over 
the study time period and was therefore not included in the analysis.
○
1. 
Mention is made of a variety of specimen types that were tested for respiratory viruses in 
the study. Is there evidence to suggest that any one type gives better yields than others? 
This should be elaborated on briefly in the discussion section, potentially as a limitation of 
the study. 
 
2. 
The authors mention that an alternative attribution could be made in 26% of cases that died 
with a positive detection of HCoV in their study (page 9, left hand column, third sentence); 
however, this in not explored at all in the Results Section. This should be presented in the 
Results section, so as to contextualise the assertion made in the Discussion.
3. 
Minor comments:
Suggest change the title to reflect that paediatric pneumonia was the focus of attention in 
this study. Suggest “Surveillance of endemic human coronaviruses (HCoV-NL63, OC43 and 
229E) associated with childhood pneumonia in Kilifi, Kenya”. 
 
1. 
Correct the redundant double comma in affiliation 2 at the top of the title page of the 
manuscript. 
 
2. 
In the results section of the Abstract, qualify that 3.9% of the pneumonia admissions tested 
positive for at least one of the three endemic HCoVs surveyed in the study. 
 
3. 
It is unclear what is meant by “no age-dependence in the proportion testing positive” for 
HCoV in the abstract. Suggest omit this ambiguous phrase. Rather state “… n=208), and 
there was no clear seasonal pattern of HCoV infection. HCoV-OC43 was predominant…” 
 
4. 
Suggest reword the Abstract conclusions as “… co-occurring with another respiratory virus, 
no clear seasonal pattern, and with the age-distribution…” 
 
5. 
Suggest omit the speculation as to the impact of SARS-CoV-2 at the end of the last sentence 
of the Abstract. 
 
6. 
At the end of the Introduction, suggest reword as “Our study aims to describe the 
circulation patterns of three of the endemic HCoVs (OC43, 229E, and NL63) over time…” 
 
7. 
Suggest omit the definite article in the first sentence of the Methods section, i.e. “… in 2007 
for long-term continuous respiratory virus surveillance among…” 
 
8. 
Consider amending slight punctuation errors in page 3, including:
Left column, six lines from the bottom: “… ≥37.5°C, oxygen…” 
 
○
9. 
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Right column, second line: “… alive or dead).”○
There are two mentions of which viruses were tested for on page 3: suggest concatenate 
into one mention (probably best placed in the “Laboratory methods” paragraph). Reword at 
the bottom of page 3 on the right hand column to “… or very severe), laboratory test results, 
and hospitalisation outcomes…” 
 
10. 
The link to code in Extended data is not currently active in the manuscript: please correct 
this. 
 
11. 
At the bottom of page 3, suggest reword as “Untested cases did not differ… more likely to 
have very severe pneumonia (40.0% versus 28.3%; Χ2=152.5, P<0.001).”
Why resort to the use of Fisher’s exact P-value in the analysis of tested and untested 
cases (the Chi-square P-value is every bit as “significant”)?
○
12. 
Children are not “samples”: suggest reword the sentence at the top of page 4 as “Of the 
7957 children tested, 5312 (66.7%) were aged <1 year, 1454…” 
 
13. 
Suggest clarify the meaning of the second sentence on page 4 as follows: “The proportion of 
tested individuals with fever (axillary temperature ≥37.5°C), cough, and difficulty breathing 
was 58.3%, 83.2% and 92.6%, respectively.” 
 
14. 
On page 4, suggest reword the third last line on the left hand column as “… testing positive 
for HCoV (3.9%) did not vary with age group…” 
 
15. 
In Table 1, suggest present Age (months) as median and interquartile range only. 
 
16. 
In Table 1, rather use the term “Difficulty breathing” which is more widely used than 
“Breathing difficulty”, also use “Prostration” rather than “Prostrate/unconscious”. 
 
17. 
There are typos in the footnote to Table 1: “tde” should be “the”; “breatding difficulty” should 
be “difficulty breathing”; “witd” should be “with”. 
 
18. 
Suggest reword the first sentence under the heading “Clinical outcomes of HCoV-infected 
patients” on page 5 as: “… positive for at least one of the three endemic HCoVs investigated 
for in this study were admitted to…” 
 
19. 
In Figure 1, the HCoV-OC43 figure y-axis requires correction of spelling of the word 
“immunosuppression”; the HCoV-229E figure requires change of the “Malnutrition & 
immunosuppression” label on the y-axis to have an initial capital “M”. 
 
20. 
Suggest reword the first sentence under the heading “Temporal patterns of different 
HCoVs” on page 5 as: “… middle of 2011, and were not detected subsequent to 2016 (Figure 
3).” 
 
21. 
In Table 2, suggest add in an analysis for all HCoVs combined. 
 
22. 
Suggest reword the first sentence of the Discussion as “… patterns of three endemic HCoVs 
(NL63, OC43 and 229E) in a… positive for one or more of the HCoVs that were investigated 
for (3.9%).” 
23. 
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Check the calculation of the comparison between Sipulwa et al and the current study, in the 
second line on the right hand column on page 9: I get Χ2=3.92, p=0.048. 
 
24. 
In the second sentence of the second paragraph on the right column on page 9, suggest 
reword to “… nor the long rainy periods (April to July) in Kilifi were associated with HCoV 
peaks.” 
 
25. 
Suggest reword the fifth sentence in the right hand column on page 9 as “Of interest is that 
pneumonia associated with 229E was not detected in the later years of surveillance.” 
 
26. 
Please correct the spelling or “axillary” in the footnote to Table 2. 
 
27. 
The authors do not consider differences in participant recruitment as being a potential 
explanation as to why 229E-associated pneumonia was not detected subsequent to 2016: 
were there systematic differences in participant recruitment strategies that might have 
impacted on detection of this virus? 
 
28. 
Suggest reword the third sentence on the right hand column on page 10 as “It should be 
noted that fever, either on history or as measured at the time of admission, was not an 
inclusion criterion…”
29. 
 
Is the work clearly and accurately presented and does it cite the current literature?
Yes
Is the study design appropriate and is the work technically sound?
Yes
Are sufficient details of methods and analysis provided to allow replication by others?
Yes
If applicable, is the statistical analysis and its interpretation appropriate?
Yes
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Partly
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Paediatric pneumonia aetiology; paediatric infectious diseases.
I confirm that I have read this submission and believe that I have an appropriate level of 
expertise to confirm that it is of an acceptable scientific standard, however I have 
significant reservations, as outlined above.
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Author Response 07 Sep 2020
Grieven Otieno, Kenya Medical Research Institute-Wellcome Trust Research Programme, 
Kilifi, Kenya 
Major comments:
Why was HCoV-HKU1 not included in the surveillance of endemic human 
coronaviruses in this
1. 
study? Lack of testing for HCoV-HKU1 should be mentioned as a limitation of the study. 
PERCH samples were included in the analysis, which would have included HCoV-HCoV-
HKU1: mention should be made that, as HKU1 was only tested for in the 24-month PERCH 
surveillance period, it was considered to be under-represented over the study time period 
and was therefore not included in the analysis. 
  
Response: We thank the reviewer for pointing this out. We have edited the manuscript as 
advised by the reviewer. 
 
Mention is made of a variety of specimen types that were tested for respiratory 
viruses in the study. Is there evidence to suggest that any one type gives better yields 
than others? This should be elaborated on briefly in the discussion section, potentially 
as a limitation of the study.
1. 
  
Response: We thank the reviewer for pointing this out. We have added the following statement 
to the limitations of the study 
“We employed various collection methods and these are known to differ in the range of viruses 
detected. For example, the addition of an OP swab to an NP  swab has been found to increase 
virus yield” 
 
The authors mention that an alternative attribution could be made in 26% of cases 
that died with a
1. 
positive detection of HCoV in their study (page 9, left hand column, third sentence); 
however, this 
in not explored at all in the Results Section. This should be presented in the Results section, 
so as 
to contextualise the assertion made in the Discussion. 
Response: We have expanded the statements in the results section to refer to the proportion of 
individuals and made adjustments to the discussion section. 
  
Minor comments: 
 
Suggest change the title to reflect that paediatric pneumonia was the focus of 
attention in this
1. 
study. Suggest “Surveillance of endemic human coronaviruses (HCoV-NL63, OC43 and 229E) 
associated with childhood pneumonia in Kilifi, Kenya”. 
Response: We have made the change as suggested by the reviewer. 
 
Correct the redundant double comma in affiliation 2 at the top of the title page of the 1. 
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manuscript.
  
Response: We have made the change as suggested by the reviewer. 
 
In the results section of the Abstract, qualify that 3.9% of the pneumonia admissions 
tested positive
1. 
for at least one of the three endemic HCoVs surveyed in the study. 
Response: We have made the change as suggested by the reviewer. 
 
It is unclear what is meant by “no age-dependence in the proportion testing positive” 
for HCoV in
1. 
the abstract. Suggest omit this ambiguous phrase. Rather state “… n=208), and there was no 
clear 
seasonal pattern of HCoV infection. HCoV-OC43 was predominant…” 
  
Response: We have adjusted the statement in the abstract but would wish to retain the 
rest. Although there were more cases in the younger age groups this simply reflected the 
more eligible admissions. 
 
Suggest reword the Abstract conclusions as “… co-occurring with another respiratory 
virus, no
1. 
clear seasonal pattern, and with the age-distribution…” 
  
Response: We have made the change as suggested by the reviewer. 
  
 
Suggest omit the speculation as to the impact of SARS-CoV-2 at the end of the last 
sentence of the
1. 
Abstract. 
  
Response: We have made the change as suggested by the reviewer. 
 
At the end of the Introduction, suggest reword as “Our study aims to describe the 
circulation
1. 
patterns of three of the endemic HCoVs (OC43, 229E, and NL63) over time…” 
  
Response: We have made the change as suggested by the reviewer. 
 
Suggest omit the definite article in the first sentence of the Methods section, i.e. “… in 
2007 for
1. 
long-term continuous respiratory virus surveillance among…” 
  
Response: We have made the change as suggested by the reviewer. 
 
Consider amending slight punctuation errors in page 3, including:1. 
Left column, six lines from the bottom: “… ≥37.5°C, oxygen…” 
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Right column, second line: “… alive or dead).” 
  
Response: We have made the change as suggested by the reviewer. 
 
There are two mentions of which viruses were tested for on page 3: suggest 
concatenate into one
1. 
mention (probably best placed in the “Laboratory methods” paragraph). Reword at the 
bottom of 
page 3 on the right hand column to “… or very severe), laboratory test results, and 
hospitalisation 
outcomes…” 
  
Response: We have made the change as suggested by the reviewer. 
 
The link to code in Extended data is not currently active in the manuscript: please 
correct this.
1. 
  
Response: We have corrected the error with the  link and it is now active. 
 
At the bottom of page 3, suggest reword as “Untested cases did not differ… more 
likely to have
1. 
very severe pneumonia (40.0% versus 28.3%; Χ =152.5, P<0.001).” Why resort to the use of 
Fisher’s exact P-value in the analysis of tested and untested cases (the Chi-square P-value is 
every bit as “significant”)? 
  
Response: Fisher’s exact p-value is reported because of the low expected counts (<5)  in the older 
age bands 
 
Children are not “samples”: suggest reword the sentence at the top of page 4 as “Of 
the 7957
1. 
children tested, 5312 (66.7%) were aged <1 year, 1454…” 
  
Response: We have made the change as suggested by the reviewer. 
 
Suggest clarify the meaning of the second sentence on page 4 as follows: “The 
proportion of
1. 
tested individuals with fever (axillary temperature ≥37.5°C), cough, and difficulty breathing 
was 
58.3%, 83.2% and 92.6%, respectively.” 
  
Response: We have made the change as suggested by the reviewer. 
 
On page 4, suggest reword the third last line on the left hand column as “… testing 
positive for
1. 
HCoV (3.9%) did not vary with age group…” 
  
Response: We have made the change as suggested by the reviewer. 
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In Table 1, suggest present Age (months) as median and interquartile range only.1. 
  
Response: We have made the change as suggested by the reviewer. 
 
In Table 1, rather use the term “Difficulty breathing” which is more widely used than 
“Breathing
1. 
difficulty”, also use “Prostration” rather than “Prostrate/unconscious”. 
Response: We have made the change as suggested by the reviewer. 
 
There are typos in the footnote to Table 1: “tde” should be “the”; “breatding difficulty” 
should be
1. 
“difficulty breathing”; “witd” should be “with”. 
Response: We have made the change as suggested by the reviewer. 
 
Suggest reword the first sentence under the heading “Clinical outcomes of HCoV-
infected patients”
1. 
on page 5 as: “… positive for at least one of the three endemic HCoVs investigated for in this 
study 
were admitted to…” 
Response: We have made the change as suggested by the reviewer. 
 
In Figure 1, the HCoV-OC43 figure y-axis requires correction of spelling of the word1. 
“immunosuppression”; the HCoV-229E figure requires change of the “Malnutrition & 
immunosuppression” label on the y-axis to have an initial capital “M”. 
Response: We have made the change as suggested by the reviewer. 
 
Suggest reword the first sentence under the heading “Temporal patterns of different 
HCoVs” on
1. 
page 5 as: “… middle of 2011, and were not detected subsequent to 2016 (Figure 3).” 
  
Response: We have made the change as suggested by the reviewer. 
  
 
In Table 2, suggest add in an analysis for all HCoVs combined.1. 
  
Response: We have made the change as suggested by the reviewer. 
  
 
Suggest reword the first sentence of the Discussion as “… patterns of three endemic 
HCoVs
1. 
(NL63, OC43 and 229E) in a… positive for one or more of the HCoVs that were investigated 
for 
(3.9%).” 
  
Response: We have made the change as suggested by the reviewer. 
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Check the calculation of the comparison between Sipulwa et al and the current study, 
in the
1. 
second line on the right hand column on page 9: I get Χ =3.92, p=0.048. 
  
Response: We have made the change as suggested by the reviewer. 
 
In the second sentence of the second paragraph on the right column on page 9, 
suggest reword to
1. 
“… nor the long rainy periods (April to July) in Kilifi were associated with HCoV peaks.” 
Response: We have made the change as suggested by the reviewer. 
  
 
Suggest reword the fifth sentence in the right hand column on page 9 as “Of interest 
is that
1. 
pneumonia associated with 229E was not detected in the later years of surveillance.” 
Response: We have made the change as suggested by the reviewer. 
 
Please correct the spelling or “axillary” in the footnote to Table 2.1. 
Response: We have made the change as suggested by the reviewer. 
 
The authors do not consider differences in participant recruitment as being a 
potential explanation as to why 229E-associated pneumonia was not detected 
subsequent to 2016: were there systematic differences in participant recruitment 
strategies that might have impacted on detection of this virus?
1. 
Response:  We have made the change as suggested by the reviewer. 
 
Suggest reword the third sentence on the right hand column on page 10 as “It should 
be noted that fever, either on history or as measured at the time of admission, was 
not an inclusion criterion…”
1. 
  
Response:  We have made the change as suggested by the reviewer.  
Competing Interests: No competing interests declared
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